Published in Obes Surg on April 01, 2001
Prevalence of alcohol use disorders before and after bariatric surgery. JAMA (2012) 2.02
High-risk alcohol use after weight loss surgery. Surg Obes Relat Dis (2014) 1.45
Predictors of success after laparoscopic gastric bypass: a multivariate analysis of socioeconomic factors. Surg Endosc (2006) 1.42
Capacity for physical activity predicts weight loss after Roux-en-Y gastric bypass. Obesity (Silver Spring) (2008) 1.17
Psychiatric considerations of the massive weight loss patient. Clin Plast Surg (2008) 0.96
Comparison of comorbidity resolution and improvement between laparoscopic sleeve gastrectomy and laparoscopic adjustable gastric banding. Surg Endosc (2010) 0.93
Prevalence of preoperative alcohol abuse among patients seeking weight-loss surgery. Surg Endosc (2012) 0.92
Psychopathology in bariatric surgery candidates: a review of studies using structured diagnostic interviews. Compr Psychiatry (2013) 0.89
History of smoking and postcessation weight gain among weight loss surgery candidates. Addict Behav (2007) 0.85
The Italian Group for LAP-BAND: predictive value of initial body mass index for weight loss after 5 years of follow-up. Surg Endosc (2004) 0.83
Mental Health Evaluations for Adolescents Prior to Bariatric Surgery: A Review of Existing Practices and a Specific Example of Assessment Procedures. Clin Obes (2013) 0.81
A comparison of laparoscopic adjustable gastric banding in adolescents and adults. Surg Endosc (2003) 0.81
Preoperative factors and 3-year weight change in the Longitudinal Assessment of Bariatric Surgery (LABS) consortium. Surg Obes Relat Dis (2015) 0.81
Metabolic changes one year after laparoscopic adjustable gastric banding operation in morbidly obese subjects. Wideochir Inne Tech Maloinwazyjne (2012) 0.80
Suicidal Ideation and Behaviours Among Adolescents Receiving Bariatric Surgery: A Case-Control Study. Eur Eat Disord Rev (2015) 0.78
Endoscopic Treatment of Diverse Complications Caused by Laparoscopic Adjustable Gastric Banding: A Study in Eastern Asia. Gut Liver (2017) 0.75
Pre-operative history of depression and cognitive changes in bariatric surgery patients. Psychol Health Med (2014) 0.75
Impaired weight loss in laparoscopic adjustable gastric banding patients over 50 years of age: diabetes mellitus as an independent risk factor. Surg Endosc (2015) 0.75
Laparoscopic Adjustable Gastric Banding: Predictive Factors for Weight Loss and Band Removal After More than 10 Years' Follow-Up in a Single University Unit. World J Surg (2017) 0.75
Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology (2001) 5.07
Genetic evidence on the origins of Indian caste populations. Genome Res (2001) 3.25
Deep common ancestry of indian and western-Eurasian mitochondrial DNA lineages. Curr Biol (1999) 3.06
The distribution of human genetic diversity: a comparison of mitochondrial, autosomal, and Y-chromosome data. Am J Hum Genet (2000) 2.91
Changes in fat-free mass during significant weight loss: a systematic review. Int J Obes (Lond) (2006) 1.79
The "ART" of thromboembolism: a review of assisted reproductive technology and thromboembolic complications. Thromb Res (2007) 1.78
Night eating syndrome and nocturnal snacking: association with obesity, binge eating and psychological distress. Int J Obes (Lond) (2007) 1.69
Gastric surgery for morbid obesity. The Adelaide Study. Ann Surg (1990) 1.65
Female gene flow stratifies Hindu castes. Nature (1998) 1.60
Sulphated macromolecules produced by in vivo labelling in the rat gastric mucosa. J Gastroenterol Hepatol (1995) 1.42
The spectrum of mutations in TBX3: Genotype/Phenotype relationship in ulnar-mammary syndrome. Am J Hum Genet (1999) 1.41
Marked improvement in asthma after Lap-Band surgery for morbid obesity. Obes Surg (1999) 1.27
A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Arch Surg (1993) 1.24
Quality of life after lap-band placement: influence of time, weight loss, and comorbidities. Obes Res (2001) 1.23
Effect of gastric secretory inhibitors on the gastric mucosal barrier. Gut (1975) 1.21
Microvascular architecture of experimental colon tumors in the rat. Cancer Res (1990) 1.16
Multiple origins of the mtDNA 9-bp deletion in populations of South India. Am J Phys Anthropol (1999) 1.16
Polysomnography before and after weight loss in obese patients with severe sleep apnea. Int J Obes (Lond) (2005) 1.13
Characterization of an animal model of hepatic metastasis. J Gastroenterol Hepatol (1996) 1.09
Gastroesophageal reflux in obesity: the effect of lap-band placement. Obes Surg (1999) 1.06
Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment. Diabet Med (2003) 1.05
Effect of nonsteroidal anti-inflammatory drugs on LFA-1 and ICAM-1 expression in gastric mucosa. Am J Physiol (1994) 1.05
Noradrenergic nerves in human small intestine. Distribution and ultrastructure. Gastroenterology (1984) 1.03
Body composition changes following laparoscopic gastric banding for morbid obesity. Acta Diabetol (2003) 1.01
The microvascular structure of the normal colon in rats and humans. J Surg Res (1996) 1.00
Sleep disturbance and obesity: changes following surgically induced weight loss. Arch Intern Med (2001) 1.00
Microvascular structure of benign and malignant tumors of the colon in humans. Dig Dis Sci (1995) 0.98
Mitochondrial DNA variation in Nicobarese Islanders. Hum Biol (2001) 0.97
Protection against gastric ischemia-reperfusion injury by nitric oxide generators. Dig Dis Sci (1994) 0.96
Hypernatremia, azotemia, and dehydration ue to high-protein tube feeding. Ann Intern Med (1968) 0.95
Distributions of neuropeptides in the human esophagus. Gastroenterology (1987) 0.93
Inhibition of beta-catenin translocation in rodent colorectal tumors: a novel explanation for the protective effect of nonsteroidal antiinflammatory drugs in colorectal cancer. Dig Dis Sci (2001) 0.91
Combretastatin A4 prodrug study of effect on the growth and the microvasculature of colorectal liver metastases in a murine model. Clin Cancer Res (2001) 0.91
Inhibition of colon cancer precursors in the rat by sulindac sulphone is not dependent on inhibition of prostaglandin synthesis. J Gastroenterol Hepatol (1996) 0.89
Reduced plasma homocysteine in obese red wine consumers: a potential contributor to reduced cardiovascular risk status. Eur J Clin Nutr (2002) 0.88
Management of diffuse peritonitis by prolonged postoperative peritoneal lavage. Aust N Z J Surg (1987) 0.87
Polymorphonuclear leukocyte infiltration into gastric mucosa after ischemia-reperfusion. Am J Physiol (1994) 0.87
Microvascular architecture of hepatic metastases in a mouse model. HPB Surg (1997) 0.86
Reconstructing the history of human limb development: lessons from birth defects. Pediatr Res (1999) 0.86
Granulocyte apheresis in inflammatory bowel disease: possible mechanisms of effect. Ther Apher (1998) 0.86
Axis I disorders in adjustable gastric band patients: the relationship between psychopathology and weight loss. Obes Surg (2014) 0.84
Pregnancy after Lap-Band surgery: management of the band to achieve healthy weight outcomes. Obes Surg (2001) 0.84
Sequence of gastric mucosal injury following ischemia and reperfusion. Role of reactive oxygen metabolites. Dig Dis Sci (1992) 0.83
Sulindac inhibits the rate of growth and appearance of colon tumors in the rat. Arch Surg (1991) 0.83
Inhibition of rat colon tumors by sulindac and sulindac sulfone is independent of K-ras (codon 12) mutation. Am J Physiol Gastrointest Liver Physiol (2000) 0.83
5-aminosalicyclic acid and olsalazine inhibit tumor growth in a rodent model of colorectal cancer. Dig Dis Sci (2000) 0.83
Sulindac inhibits colorectal tumour growth, but not prostaglandin synthesis in the rat. J Gastroenterol Hepatol (1998) 0.83
The endosurgical revolution: is it under control? Aust N Z J Surg (1994) 0.82
Misoprostol hepatoprotection against ischemia-reperfusion-induced liver injury in the rat. Dig Dis Sci (1992) 0.82
Effects of misoprostol on delayed ulcer healing induced by aspirin. Dig Dis Sci (1994) 0.81
Photoperiod history, melatonin, and reproductive responses of male Syrian hamsters. J Pineal Res (1990) 0.81
Sulindac and indomethacin inhibit formation of aberrant crypt foci in the colons of dimethyl hydrazine treated rats. J Gastroenterol Hepatol (1996) 0.81
Brown adipocyte progenitor population is modified in obese and diabetic skeletal muscle. Int J Obes (Lond) (2011) 0.81
Cyclooxygenase-1 and an alternatively spliced mRNA in the rat stomach: effects of aging and ulcers. Am J Physiol Gastrointest Liver Physiol (2000) 0.81
Patient well-being after gastric bypass surgery for morbid obesity. Aust N Z J Surg (1983) 0.81
Tamoxifen inhibits colorectal cancer metastases in the liver: a study in a murine model. J Gastroenterol Hepatol (1998) 0.81
NSAID-induced delay in gastric ulcer healing is not associated with decreased epithelial cell proliferation in rats. Dig Dis Sci (1995) 0.80
Substance P-containing nerves in the human small intestine. Distribution, ultrastructure, and characterization of the immunoreactive peptide. Gastroenterology (1984) 0.80
Elevated homocysteine levels with weight loss after Lap-Band surgery: higher folate and vitamin B12 levels required to maintain homocysteine level. Int J Obes Relat Metab Disord (2001) 0.79
Rat colorectal tumours treated with a range of non-steroidal anti-inflammatory drugs show altered cyclooxygenase-2 and cyclooxygenase-1 splice variant mRNA expression levels. Carcinogenesis (2001) 0.78
Acetaminophen-induced microvascular injury in the rat liver: protection with misoprostol. Hepatology (1995) 0.78
Expression of adhesion molecules and leukocyte recruitment into gastric mucosa following ischemia-reperfusion. Dig Dis Sci (1997) 0.78
Abnormalities of peptide-containing nerve fibers in infantile hypertrophic pyloric stenosis. Gastroenterology (1987) 0.78
Misoprostol protection against acetaminophen-induced hepatotoxicity in the rat. Dig Dis Sci (1994) 0.78
Microvascular changes in liver after ischemia-reperfusion injury. Protection with misoprostol. Dig Dis Sci (1994) 0.77
Non-steroidal anti-inflammatory drugs with different cyclooxygenase inhibitory profiles that prevent aberrant crypt foci formation but vary in acute gastrotoxicity in a rat model. J Gastroenterol Hepatol (2000) 0.76
GPR119 regulates genetic markers of fatty acid oxidation in cultured skeletal muscle myotubes. Mol Cell Endocrinol (2012) 0.76
"The hospital isn't closed--we've just relocated"--a New Brunswick disaster plan. Can Med Assoc J (1979) 0.75
Screening, case finding and evidence-based guidelines. Med J Aust (1999) 0.75
A complication of stapling the stomach in gastric bypass for obesity. Br J Surg (1980) 0.75
Clinical practice guidelines. Med J Aust (1996) 0.75
President's message. Occup Health Nurs (1971) 0.75
The role of luminal factors in prostaglandin protection against ethanol-induced gastric mucosal injury. J Gastroenterol Hepatol (1993) 0.75
Influence of age on natural and delayed healing of experimentally-induced gastric ulcers in rats. Dig Dis Sci (1996) 0.75
President's message. Occup Health Nurs (1972) 0.75
Changes in sulfated macromolecules produced in vivo during normal and indomethacin-delayed ulcer healing in rats. Dig Dis Sci (1997) 0.75
Training in surgery--training in research. Aust N Z J Surg (1988) 0.75
The surgical treatment of morbid obesity: current status and prospects. Med J Aust (1994) 0.75
On the possible role of prostaglandin E2 in intestinal stasis in the gastric brooding frog Rheobatrachus silus. Aust J Exp Biol Med Sci (1984) 0.75
Inability of cytoprotection to occur during a period of gastric ischemia. Dig Dis Sci (1991) 0.75
Smooth hospital evacuation in New Brunswick. Emerg Plann Dig (1979) 0.75
Time as a factor in the expression of ethanol injury to the gastric mucosa. J Gastroenterol Hepatol (1991) 0.75
Tiaprofenic acid inhibits mucosal prostaglandin E2 synthesis without delaying experimental gastric ulcer healing. J Gastroenterol Hepatol (1998) 0.75
Where should our new doctors come from? CMAJ (1993) 0.75
The president's annual report. Occup Health Nurs (1972) 0.75
President's message. Occup Health Nurs (1972) 0.75
President's message. Occup Health Nurs (1971) 0.75